Other languages Vertex Pharmaceuticals Incorporated

Equities

VRTX

US92532F1003

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
455.3 ^USD	+2.77%		-0.35%	+11.91%

May. 31	BMO Capital Adjusts Price Target on Vertex Pharmaceuticals to $500 From $480	MT
May. 31	Vertex Pharmaceuticals Insider Sold Shares Worth $1,478,068, According to a Recent SEC Filing	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BMO Capital Adjusts Price Target on Vertex Pharmaceuticals to $500 From $480	May. 31
Vertex Pharmaceuticals Insider Sold Shares Worth $1,478,068, According to a Recent SEC Filing	May. 31
Vertex Pharmaceuticals Insider Sold Shares Worth $715,205, According to a Recent SEC Filing	May. 29
Vertex Pharmaceuticals Insider Sold Shares Worth $3,168,704, According to a Recent SEC Filing	May. 24
Vertex Pharmaceuticals Insider Sold Shares Worth $6,795,294, According to a Recent SEC Filing	May. 22
Vertex to Participate in Upcoming June Investor Conferences	May. 22
ADDvise Group’s Axelerist Bags $1.4 Million Order for Medical, Lab Equipment	May. 21
Vertex Pharmaceuticals Incorporated completed the acquisition of Alpine Immune Sciences, Inc. from a group of shareholders.	May. 19
Declaration of Voting Results by Vertex Pharmaceuticals Incorporated	May. 15
Declaration of Voting Results by Vertex Pharmaceuticals Incorporated	May. 15
Jennifer Schneider Elected to Vertex Board of Directors	May. 15
Vertex Pharmaceuticals Incorporated Appoints Jennifer Schneider as Independent Director	May. 15
Wolfe Research Adjusts Price Target on Vertex Pharmaceuticals to $520 From $497	May. 14
Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone	May. 10
FOMO is Back	May. 07
ANALYST RECOMMENDATIONS : Nvidia, The Home Depot, Lowe's, Rollins...	May. 07
Leerink Partners Adjusts Vertex Pharmaceuticals' Price Target to $529 From $511	May. 07
Stifel Adjusts Vertex Pharmaceuticals' Price Target to $420 From $430	May. 07
Piper Sandler Adjusts Price Target on Vertex Pharmaceuticals to $456 From $450, Keeps Overweight Rating	May. 07
Morgan Stanley Adjusts Price Target on Vertex Pharmaceuticals to $402 From $413, Keeps Equalweight Rating	May. 07

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Vertex Pharmaceuticals Incorporated : Vertex and Crispr to market $2.2 million treatment for sickle cell disease

December 11, 2023 at 05:47 am EST